Candidate genes that affect aging through protein homeostasis

Advances in Experimental Medicine and Biology

Volumn 847, Issue , 2015, Pages 45-72

  Argon, Yair ^a   Gidalevitz, Tali ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P53; PROTEOME; SIRTUIN; SOMATOMEDIN; PROTEINS; SIRTUINS; SOMATOMEDINS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

AGE; AGING; ARTICLE; CALORIC RESTRICTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE IDENTIFICATION; GONAD; HORMESIS; HUMAN; LIFESPAN; LONGEVITY; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STRESS; ANIMALS; GENETICS; HOMEOSTASIS; HUMANS; PHYSIOLOGY;

AGING; ANIMALS; HOMEOSTASIS; HUMANS; LONGEVITY; PROTEIN FOLDING; PROTEINS; SIRTUINS; SOMATOMEDINS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84929484253     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2404-2_2     Document Type: Article

References (172)

1. Kenyon CJ (2010) The genetics of ageing. Nature 464(7288):504–512
2. Lopez-Otin C et al (2013) The hallmarks of aging. Cell 153(6):1194–1217
3. Sahin E, Depinho RA (2010) Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464(7288):520–528
4. Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev 88(2):557–579
5. Soerensen M (2012) Genetic variation and human longevity. Dan Med J 59(5):B4454
6. Murabito JM, Yuan R, Lunetta KL (2012) The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J Gerontol A Biol Sci Med Sci 67(5):470–479
7. Suri S et al (2013) The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2. Neurosci Biobehav Rev 37(10 Pt 2):2878–2886
8. Kulminski AM et al (2013) The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell 12(2):237–246
9. Baraibar MA, Ladouce R, Friguet B (2013) Proteomic quantification and identification of carbonylated proteins upon oxidative stress and during cellular aging. J Proteomics 92:63–70
10. Cabiscol E, Tamarit J, Ros J (2014) Protein carbonylation: proteomics, specificity and relevance to aging. Mass Spectrom Rev 33(1):21–48
11. Perluigi M, Swomley AM, Butterfield DA (2013) Redox proteomics and the dynamic molecular landscape of the aging brain. Ageing Res Rev 13:75–89
12. Salmon AB et al (2009) The long lifespan of two bat species is correlated with resistance to protein oxidation and enhanced protein homeostasis. FASEB J 23(7):2317–2326
13. Beekman M et al (2013) Genome-wide linkage analysis for human longevity: genetics of healthy aging study. Aging Cell 12(2):184–193
14. Schachter F et al (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6(1):29–32
15. Breslow JL et al (1982) Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 23(8):1224–1235
16. Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 1411(2):137–147
17. Khan TA et al (2013) Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. Int J Epidemiol 42(2):475–492
18. Morris JC et al (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cog-nitively normal aging. Ann Neurol 67(1):122–31
19. Castellano JM et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3(89):89-57
20. Hashimoto T et al (2012) Apolipoprotein E, especially apolipoprotein E4, increases the oligo-merization of amyloid beta peptide. J Neurosci 32(43):15181–15192
21. Chen Y et al (2010) ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A 107(26):12011–12016
22. Liu CC et al (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106–118
23. Jochemsen HM et al (2012) APOE epsilon4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiol Aging 33(4):832 e15–22
24. Bloss CS et al (2008) Decreased cognition in children with risk factors for Alzheimer’s disease. Biol Psychiatry 64(10):904–906
25. Tuminello ER, Han SD (2011) The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimer’s Dis 2011:726197
26. Balch WE et al (2008) Adapting proteostasis for disease intervention. Science 319(5865):916–919
27. Gidalevitz T, Stevens F, Argon Y (2013) Orchestration of secretory protein folding by ER chaperones. Biochim Biophys Acta 1833(11):2410–2424
28. Koubova J, Guarente L (2003) How does calorie restriction work? Genes Dev 17(3):313–321
29. Cornelius C et al (2013) Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: mitochondria as a “chi”. Immun Ageing 10(1):15
30. Moreau KL, King JA (2012) Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends Mol Med 18(5):273–282
31. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10(12):524–530
32. Gidalevitz T et al (2006) Progressive disruption of cellular protein folding in models of poly-glutamine diseases. Science 311(5766):1471–1474
33. Ben-Zvi A, Miller EA, Morimoto RI (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A 106(35):14914–14919
34. Cohen E et al (2009) Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139(6):1157–1169
35. David DC et al (2010) Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol 8(8):e1000450
36. Alavez S et al (2011) Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 472(7342):226–2269
37. Alavez S, Lithgow GJ (2012) Pharmacological maintenance of protein homeostasis could postpone age-related disease. Aging Cell 11(2):187–191
38. El-Ami T et al (2014) A novel inhibitor of the insulin/IGF signaling pathway protects from age-onset, neurodegeneration-linked proteotoxicity. Aging Cell 13, 165–174
39. Gidalevitz T et al (2013) Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease. BMC Biol 11:100
40. Harrison DE et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460(7253):392–395
41. Shore DE, Ruvkun G (2013) A cytoprotective perspective on longevity regulation. Trends Cell Biol 23(9):409–420
42. Perez VI et al (2009) Is the oxidative stress theory of aging dead? Biochim Biophys Acta 1790(10):1005–1014
43. Van Raamsdonk JM, Hekimi S (2012) Superoxide dismutase is dispensable for normal animal lifespan. Proc Natl Acad Sci U S A 109(15):5785–5790
44. Kikis EA, Gidalevitz T, Morimoto RI (2010) Protein homeostasis in models of aging and age-related conformational disease. Adv Exp Med Biol 694:138–159
45. Morimoto RI (2008) Proteotoxic stress and inducible chaperone networks in neurodegenera-tive disease and aging. Genes Dev 22(11):1427–1438
46. Heydari AR et al (1994) Hsp70 and aging. Experientia 50(11–12):1092–1098
47. Singh R et al (2006) Reduced heat shock response in human mononuclear cells during aging and its association with polymorphisms in HSP70 genes. Cell Stress Chaperones 11(3):208–215
48. Liu AY et al (1989) Heat shock induction of HSP 89 is regulated in cellular aging. Biochem Biophys Res Commun 162(3):1302–1310
49. Shamovsky I, Gershon D (2004) Novel regulatory factors of HSF-1 activation: facts and perspectives regarding their involvement in the age-associated attenuation of the heat shock response. Mech Ageing Dev 125(10–11):767–775
50. Shemesh N, Shai N, Ben-Zvi A (2013) Germline stem cell arrest inhibits the collapse of somatic proteostasis early in Caenorhabditis elegans adulthood. Aging Cell 12(5):814–822
51. Swindell WR et al (2009) Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice. Mech Ageing Dev 130(6):393–400
52. Elefant F, Palter KB (1999) Tissue-specific expression of dominant negative mutant Dro-sophila HSC70 causes developmental defects and lethality. Mol Biol Cell 10(7):2101–2117
53. Feder JH et al (1992) The consequences of expressing hsp70 in Drosophila cells at normal temperatures. Genes Dev 6(8):1402–1413
54. Nylandsted J, Brand K, Jaattela M (2000) Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci 926:122–125
55. Whitesell L et al (1994) Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in onco-genic transformation. Proc Natl Acad Sci U S A 91(18):8324–8328
56. Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer Nat Rev Cancer 5(10):761–72
57. Taylor RC, Dillin A (2013) XBP-1 is a cell-nonautonomous regulator of stress resistance and longevity. Cell 153(7):1435–1447
58. Yamagishi N, Saito Y, Hatayama T (2008) Mammalian 105 kDa heat shock family proteins suppress hydrogen peroxide-induced apoptosis through a p38 MAPK-dependent mitochon-drial pathway in HeLa cells. FEBS J 275(18):4558–4570
59. Swindell WR (2008) Comparative analysis of microarray data identifies common responses to caloric restriction among mouse tissues. Mech Ageing Dev 129(3):138–153
60. Shpund S, Gershon D (1997) Alterations in the chaperone activity of HSP70 in aging organisms. Arch Gerontol Geriatr 24(2):125–131
61. Erickson RR, Dunning LM, Holtzman JL (2006) The effect of aging on the chaperone concentrations in the hepatic, endoplasmic reticulum of male rats: the possible role of protein misfolding due to the loss of chaperones in the decline in physiological function seen with age. J Gerontol A Biol Sci Med Sci 61(5):435–443
62. Rutkowski DT et al (2007) The role of p58IPK in protecting the stressed endoplasmic reticu-lum. Mol Biol Cell 18(9):3681–3691
63. Ladiges WC et al (2005) Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK. Diabetes 54(4):1074–1081
64. Hetz CA, Soto C (2006) Emerging roles of the unfolded protein response signaling in physiology and disease. Curr Mol Med 6(1):1
65. Pastore N et al (2013) Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency. EMBO Mol Med 5(3):397–412
66. Hetz C et al (2008) Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc Natl Acad Sci U S A 105(2):757–762
67. Hetz C et al (2009) XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23(19):2294–2306
68. Tomaru U et al (2012) Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol 180(3):963–972
69. Yun C et al (2008) Proteasomal adaptation to environmental stress links resistance to proteo-toxicity with longevity in Caenorhabditis elegans. Proc Natl Acad Sci U S A 105(19):7094–7099
70. Hipp MS et al (2012) Indirect inhibition of 26 S proteasome activity in a cellular model of Huntington’s disease. J Cell Biol 196(5):573–587
71. Tsakiri EN et al (2013) Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell 12(5):802–813
72. Davis DP et al (2000) Inhibition of amyloid fiber assembly by both BiP and its target peptide. Immunity 13(4):433–442
73. Cuervo AM, Wong E (2014) Chaperone-mediated autophagy: roles in disease and aging. Cell Res 24(1):92–104
74. Toth ML et al (2008) Longevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans. Autophagy 4(3):330–338
75. Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143(7):1883–1898
76. Wang Y et al (2009) Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 23(2):451–463
77. Zaarur N et al (2008) Triggering aggresome formation. Dissecting aggresome-targeting and aggregation signals in synphilin 1. J Biol Chem 283(41):27575–27584
78. Tsakiri EN et al (2013) Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress. FASEB J 27(6):2407–2420
79. Curran SP et al (2009) A soma-to-germline transformation in long-lived Caenorhabditis el-egans mutants. Nature 459(7250):1079–1084
80. Karunanithi S et al (1999) Neuroprotection at Drosophila synapses conferred by prior heat shock. J Neurosci 19(11):4360–4369
81. Kaiser J (2003) Hormesis. Sipping from a poisoned chalice. Science 302(5644):376–379
82. Johnson TE et al (2000) Gerontogenes mediate health and longevity in nematodes through increasing resistance to environmental toxins and stressors. Exp Gerontol 35(6–7):687–94
83. Rea SL et al (2005) A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans. Nat Genet 37(8):894–898
84. Wu D et al (2006) Visualizing hidden heterogeneity in isogenic populations of C. elegans. Exp Gerontol 41(3):261–270
85. Rea SL, Ventura N, Johnson TE (2007) Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol 5(10):e259
86. Cypser JR, Johnson TE (2002) Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity. J Gerontol A Biol Sci Med Sci 57(3):B109–114
87. Fouillet A et al (2012) ER stress inhibits neuronal death by promoting autophagy. Autophagy 8(6):915–926
88. Johnson TE, Tedesco PM, Lithgow GJ (1993) Comparing mutants, selective breeding, and transgenics in the dissection of aging processes of Caenorhabditis elegans. Genetica 91(1–3):65–77
89. Friedman DB, Johnson TE (1988) A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 118(1):75–86
90. Morris JZ, Tissenbaum HA, Ruvkun G (1996) A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382(6591):536–539
91. Kenyon C et al (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366(6454):461–464
92. Kimura KD et al (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277(5328):942–946
93. Morley JF et al (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99(16):10417–10422
94. Cohen E et al (2006) Opposing activities protect against age-onset proteotoxicity. Science 313(5793):1604–1610
95. Hsu AL, Murphy CT, Kenyon C (2003) Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300(5622):1142–1145
96. Morley JF, Morimoto RI (2004) Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell 15(2):657–664
97. Holzenberger M et al (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421(6919):182–187
98. Cohen E, Dillin A (2008) The insulin paradox: aging, proteotoxicity and neurodegenera-tion. Nat Rev Neurosci 9(10):759–767
99. Suh Y et al (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A 105(9):3438–3442
100. Tan Q et al (2013) A novel permutation test for case-only analysis identifies epistatic effects on human longevity in the FOXO gene family. Aging Cell 12(4):690–694
101. Anselmi CV et al (2009) Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res 12(2):95–104
102. Willcox BJ et al (2008) FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 105(37):13987–13992
103. Flachsbart F et al (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106(8):2700–2705
104. Laron Z (2008) The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens) 7(1):24–27
105. Deelen J et al (2013) Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) 35(1):235–249
106. Holzenberger M et al (2000) A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 141(7):2557–2566
107. Abuzzahab MJ et al (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349(23):2211–2222
108. Xu J et al (2014) Longevity effect of IGF-1R(+/–) mutation depends on genetic background-specific receptor activation. Aging Cell 13(1):19–28
109. Sonntag WE et al (2013) Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front Aging Neurosci 5:27
110. Gong Z et al (2014) Reductions in serum IGF-1 during aging impair health span. Aging Cell 13, 408–418
111. Yang J, Anzo M, Cohen P (2005) Control of aging and longevity by IGF-I signaling. Exp Gerontol 40(11):867–872
112. Boccitto M, Lamitina T, Kalb RG (2012) Daf-2 signaling modifies mutant SOD1 toxicity in C. elegans. PLoS One 7(3):e33494
113. Nagano I et al (2005) Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol Res 27(7):768–772
114. Kwon ES et al (2010) A new DAF-16 isoform regulates longevity. Nature 466(7305):498–502
115. Chiang WC et al (2012) HSF-1 regulators DDL-1/2 link insulin-like signaling to heat-shock responses and modulation of longevity. Cell 148(1–2):322–334
116. Halaschek-Wiener J et al (2005) Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Res 15(5):603–615
117. Singh V, Aballay A (2006) Heat-shock transcription factor (HSF)-1 pathway required for Caenorhabditis elegans immunity. Proc Natl Acad Sci U S A 103(35):13092–13097
118. Walker GA, Lithgow GJ (2003) Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals. Aging Cell 2(2):131–139
119. Lamitina ST, Strange K (2005) Transcriptional targets of DAF-16 insulin signaling pathway protect C. elegans from extreme hypertonic stress. Am J Physiol Cell Physiol 288(2):C467–474
120. Ikeno Y et al (2003) Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci 58(4):291–296
121. Altomare K et al (2003) The allele (A)(- 110) in the promoter region of the HSP70-1 gene is unfavorable to longevity in women. Biogerontology 4(4):215–220
122. Fujikake N et al (2008) Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chap-erones. J Biol Chem 283(38):26188–26197
123. Steele AD et al (2008) Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease. Proc Natl Acad Sci U S A 105(36):13626–13631
124. Dupont J, Holzenberger M (2003) Biology of insulin-like growth factors in development. Birth Defects Res Part C Embryo Today 69(4):257–271
125. Murphy CT et al (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424(6946):277–283
126. Apfeld J, Kenyon C (1998) Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95(2):199–210
127. Wolkow CA et al (2000) Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 290(5489):147–150
128. Taguchi A, Wartschow LM, White MF (2007) Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317(5836):369–372
129. Selman C et al (2008) Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 22(3):807–818
130. Kappeler L et al (2008) Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 6(10):e254
131. Novosyadlyy R et al (2008) Insulin-like growth factor-I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum. Cell Death Differ 15(8):1304–1317
132. Pfaffenbach KT et al (2012) GRP78/BiP is a novel downstream target of IGF-1 receptor mediated signaling. J Cell Physiol 227(12):3803–3811
133. Wanderling S et al (2007) GRP94 is essential for mesoderm induction and muscle development because it regulates IGF secretion. Mol Biol Cell 18(10):3764–3775
134. Ostrovsky O, Ahmed NT, Argon Y (2009) The chaperone activity of GRP94 toward insulinlike growth factor II is necessary for the stress response to serum deprivation. Mol Biol Cell 20(6):1855–1864
135. Barton E et al (2012) Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. FASEB J 26(9):3691–3702
136. Owusu-Ansah E, Song W, Perrimon N (2013) Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell 155(3):699–712
137. Maier B et al (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev 18(3):306–319
138. Tyner SD et al (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415(6867):45–53
139. Bauer JH et al (2009) dSir2 and Dmp53 interact to mediate aspects of CR-dependent lifes-pan extension in D. melanogaster. Aging (Albany NY) 1(1):38–48
140. Bauer JH et al (2007) Expression of dominant-negative Dmp53 in the adult fly brain inhibits insulin signaling. Proc Natl Acad Sci U S A 104(33):13355–13360
141. Salih DA, Brunet A (2008) FoxO transcription factors in the maintenance of cellular ho-meostasis during aging. Curr Opin Cell Biol 20(2):126–136
142. Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253–295
143. Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73:417–435
144. Timmers S et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14(5):612–622
145. Herranz D et al (2010) Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 1:3
146. Burnett C et al (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477(7365):482–485
147. Satoh A et al (2010) SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. J Neurosci 30(30):10220–10232
148. Satoh A et al (2013) Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 18(3):416–430
149. Howitz KT et al (2003) Small molecule activators of sirtuins extend Saccharomyces cere-visiae lifespan. Nature 425(6954):191–196
150. Lakshminarasimhan M et al (2013) Sirt1 activation by resveratrol is substrate sequence-selective. Aging (Albany NY) 5(3):151–154
151. Hubbard BP et al (2013) Evidence for a common mechanism of SIRT1 regulation by al-losteric activators. Science 339(6124):1216–1219
152. Suuronen T et al (2008) Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90. Neurochem Res 33(9):1768–1775
153. Rogina B, Helfand SL (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101(45):15998–16003
154. Schmeisser K et al (2013) Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat Chem Biol 9(11):693–700
155. Mouchiroud L et al (2013) The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154(2):430–441
156. Westerheide SD et al (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323(5917):1063–1066
157. Someya S et al (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143(5):802–812
158. Jing E et al (2013) Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62(10):3404–3417
159. Vellai T et al (2003) Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426(6967):620
160. Lamming DW et al (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335(6076):1638–1643
161. Selman C et al (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326(5949):140–144
162. Miller RA et al (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66(2):191–201
163. Lamming DW et al (2013) Young and old genetically heterogeneous HET3 mice on a ra-pamycin diet are glucose intolerant but insulin sensitive. Aging Cell 12(4):712–718
164. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274–293
165. Hsu PP et al (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332(6035):1317–1322
166. Zinzalla V et al (2011) Activation of mTORC2 by association with the ribosome. Cell 144(5):757–768
167. Robida-Stubbs S et al (2012) TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab 15(5):713–724
168. Soukas AA et al (2009) Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev 23(4):496–511
169. Bjedov I et al (2010) Mechanisms of life span extension by rapamycin in the fruit fly Dro-sophila melanogaster. Cell Metab 11(1):35–46
170. Passtoors WM et al (2013) Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 12(1):24–31
171. Leontieva OV et al (2013) Dysregulation of the mTOR pathway in p53-deficient mice. Cancer Biol Ther 14(12):1182–1188
172. Miller RA et al (2014) Rapamycin-mediated lifespan increase in mice is dose and sex-dependent and appears metabolically distinct from dietary restriction. Aging Cell 13, 468–477